Healthcare & Pharmaceuticals
Your challenge: Today’s healthcare and pharmaceutical companies face challenging market conditions that offer great opportunity – and great risk. Old business models, processes and systems are no longer sufficient, especially in the face of rising demand, a shrinking workforce and continued financial pressures. Cost reduction has become a critical tool for improving profitability.
Our solution: APEX Analytix provides both software and services to help you achieve better bottom-line results, wherever in the world you do business. We help you recover overpayments, safeguard future disbursements against payment errors and fraud, streamline supplier interactions, improve cash management and mine procure-to-pay data for strategic insights that can benefit your business.
Our experience: APEX Analytix safeguards more than $1.3 trillion in disbursements for healthcare and pharmaceutical companies and other Global 1000 businesses in nearly every country in the world. We serve half of the Global Fortune 50.
Proven results: The proof of the value we deliver is found in real-world results. One example: A global leader in healthcare and pharmaceuticals turned to APEX Analytix FirstStrike® to establish a comprehensive governance platform for operations in Europe, the Middle East and Africa – protecting company disbursements against payment errors and fraud. More than €40 million in duplicate payments have been prevented to date.
“Since adopting FirstStrike, we’ve made transformative changes that are helping us improve performance and make significant inroads against disbursement errors and fraud.”
– Assistant VP, Accounting & Disbursements
Taking a Prevention-Based Approach to Global Governance
This world leader in consumer health, medical devices, diagnostics, biologics and pharmaceuticals has more than $50 billion in sales and 100,000 employees in more than 60 countries. APEX Analytix was asked to help the company shift its emphasis from detection and recovery of overpayments after the fact to a prevention-based approach, beginning with Europe, the Middle East and Africa (EMEA).